Tag: stage

FREEHOLD, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), an emerging leader in the development of non-opioid pain treatment therapeutics, today announced a 10-for-one reverse split (the “Reverse Stock Split”) of the Company’s common stock (the “Common Stock”). The Reverse Stock Split is intended to increase the market price per share of the Company’s Common Stock and help the Company satisfy the initial listing requirements of the NYSE American (the “NYSE American”) in connection with the anticipated closing of the previously announced merger of CHRO Merger Sub, Inc., a wholly owned subsidiary of the Company, with and into LNHC, Inc. and the related approximately $50 million in capital to be raised from a group of strategic investors led by Murchinson (together, the “Proposed Transactions”).

Tickets now available for the event on Friday, September 19, 2025

CALGARY, Alberta, June 26, 2025 (GLOBE NEWSWIRE) -- Acceleware^® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), is pleased to announce it has entered into an agreement (the “Marwayne Agreement”) with O’Neill Industries International-Canada Inc. (“O’Neill Canada”) that will result in the transfer of certain wells and other assets located in Marwayne, Alberta, related liabilities, licenses and leases from Acceleware to O’Neill Canada, and the termination of the existing farmout and option agreement dated May 19, 2020 between the Company and O’Neill Canada. O’Neill Canada is the Canadian entity of O’Neill Industries, a US based company active in upstream production and oil field services globally. In exchange for the above noted transfers, Acceleware will receive cash payments and a gross overriding royalty (“GORR”) on future production from the wells as described below. The Marwayne Agreement sets the stage for renewed collaboration between the Company and O’Neill Canada that includes a commitment to establish a new farmout agreement at Marwayne where Acceleware can drill new RF XL 2.0 compliant test wells in the next five years.

Tiburon, CA, June 26, 2025 (GLOBE NEWSWIRE) -- FIGX Capital Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 13,100,000 units. The units are expected to be listed on The Nasdaq Global Stock Market LLC (“Nasdaq”) and begin trading tomorrow, June 27, 2025, under the ticker symbol “FIGXU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “FIGX” and “FIGXW,” respectively. The offering is expected to close on June 30, 2025, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 1,965,000 units at the initial public offering price to cover over-allotments, if any.